| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
| Recent developments in the biotechnology sector indicate a robust growth trajectory, fueled by significant advancements in drug development and treatment options for rare diseases. The surge in investment interest showcases both the potential for high returns and the volatility inherent in biotech stocks. Discussions around biopharmaceuticals further emphasize the sector's potential market impact and clinical advancements. Overall, the focus on innovative healthcare solutions and the ongoing investment boom enhance the sector's prominence in the financial landscape. The price action of Small Biotechnology (XBI) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The market sentiment at -0.7 is bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for XBI since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for Small Biotechnology sector is at 0, and the negative at -0.7 on 2026-11-08. The forces of Market Risk Appetite (-1.8), Sentiment towards Fundamentals (-1), Broad Market Trend (-0.9), and Valuation Sentiment (-0.5) will drive down the price. The forces of Sector Price Trend (-0), Price Level Sentiment (0), and Option Sentiment (0) will drive up the price. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XBI trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice Sector Rotation Notification
| XBI | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-08 | 1%(0.4%) | -0 | -0.7 | -1 | 2.2 | |||||||||||
| 2026-11-07 | 1%(0.3%) | -0 | -0.7 | -1 | 2.5 | |||||||||||
| 2026-11-06 | 0%(0.1%) | 152.19 | 2.46% | 50 | 55 | 45 | 2.51% | 0.13% | -0 | 0.2 | 2.2% | -1 | Long | 55% | -1 | -0.5 |
| 2026-11-05 | 0%(0.1%) | 148.46 | 2.55% | 26 | 55 | 36 | -6.69% | -0.19% | -0.9 | -1.3 | 2.3% | -0.9 | Short | 55% | -1 | 7.5 |
| 2026-11-04 | 0%(0.1%) | 159.1 | 2.34% | 96 | 62 | 62 | 2.7% | 0.39% | 0.9 | 0.9 | 1.3% | -0.7 | Wait | 50% | -1 | -0.5 |
| 2026-11-03 | 0%(0.1%) | 154.91 | 2.18% | 73 | 61 | 55 | 1.84% | 0.13% | 0.1 | 0.1 | 0.9% | -1 | Long | 55% | -1 | 7.5 |
| 2026-11-02 | 1%(0.1%) | 152.11 | 2.26% | 52 | 51 | 32 | -2.44% | 0.26% | 0.3 | -0.5 | 1.4% | -0.8 | Short | 55% | -1 | 6.5 |
| 2026-11-01 | 0%(0%) | 1.2 | -0.3 | -1 | 7.5 | |||||||||||
| 2026-10-31 | 0%(0%) | 1.2 | -0.3 | -1 | -0.5 | |||||||||||
| 2026-10-30 | 0%(0.1%) | 155.91 | 2.24% | 79 | 53 | 39 | -1.19% | 0.79% | 1.2 | -0.1 | 1% | -0.7 | Wait | 50% | -1 | -0.5 |
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Market News | ||
| 1 (-6) Hims & Hers Short Interest Climbs to 23% Ahead of Earnings: Can the Stock Break Out? Hims & Hers Health stock has lost momentum this year. After peaking at $72.78 in 2025, it has slumped about 65% to the current $26. (https://www.benzinga.com/) Sun. Nov 8, 2026 | ||
| 2 (8) The Top 5 Biotech Stocks I'd Buy Right Now Without Any Hesitation These are among the best the industry has to offer. (https://www.fool.com/) Sun. Nov 8, 2026 | ||
| 3 (6) Revolution Medicines' Pancreatic Cancer Drug Nearly Doubled Survival. Is the High-Flying Stock Still a Buy? Revolution Medicines isn't profitable, but it has a drug with blockbuster potential. (https://www.fool.com/) Sun. Nov 8, 2026 | ||
| 4 (4) Cognition's Q3 Loss Declines To $4 Mln As Phase 3 For Zervimesine In Dementia Set To Begin Cognition Therapeutics Inc. (CGTX), a clinical-stage biopharmaceutical company, released financial results for the third quarter, noting a lower loss due to increased income. (https://www.rttnews.com/) Sat. Nov 7, 2026 | ||
| 5 (8) Show Me The Money: Xencor (XNCR) Delivers Triple-Digit Gains, With XENITH-UC Poised For The Next Act Shares of Xencor Inc. (XNCR), a clinical-stage biopharmaceutical company pioneering engineered antibodies for cancer and autoimmune diseases, have had a remarkable run so far this year as its clinical pipeline gathers pace and the promise of scientific advances draws investor attention. (https://www.rttnews.com/) Sat. Nov 7, 2026 | ||
| 6 (5) IYH and XBI: Two Distinct Paths to Investing in Healthcare XBI delivered stronger 1-year returns at 45%, but IYH's diversified portfolio weathered volatility far better, with a maximum drawdown of just 17.9% versus 53.2%. (https://www.fool.com/) Sat. Nov 7, 2026 | ||
| 7 (-5) The AI Wreck And The Biotech Bid ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero (https://www.zerohedge.com/) Sat. Nov 7, 2026 | ||
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA